CareMetx, a technology-enabled hub services company whose goal is to improve patient access to specialty medications; General Atlantic, a global growth equity firm; and The Vistria Group, a private investment firm, have formed a strategic partnership.
Although terms of the deal were not disclosed, General Atlantic will become the majority owner of CareMetx. The Vistria Group, an existing majority shareholder in CareMetx since 2017, will keep its significant position in the company by reinvesting through Vistria Fund III, LP. Further, Marty Nesbitt, co-CEO of The Vistria Group, will be CareMetx’s chairman.
CareMetx represents pharma and biotech companies, and looks to assist patients and providers with piloting reimbursement challenges. The plan is to continue designing solutions that can help lower the financial cost of patients’ therapy.
The post CareMetx gains pair of investments appeared first on Pharmaceutical Commerce.
